nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—Epirubicin—thyroid cancer	0.486	0.653	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—thyroid cancer	0.258	0.347	CbGbCtD
Lucanthone—APEX1—Displacement of DNA glycosylase by APE1—SMUG1—thyroid cancer	0.0154	0.0989	CbGpPWpGaD
Lucanthone—APEX1—neck—thyroid cancer	0.0152	0.183	CbGeAlD
Lucanthone—APEX1—Base-free sugar-phosphate removal via the single-nucleotide replacement pathway—SMUG1—thyroid cancer	0.0141	0.0909	CbGpPWpGaD
Lucanthone—APEX1—Resolution of AP sites via the single-nucleotide replacement pathway—SMUG1—thyroid cancer	0.0122	0.0786	CbGpPWpGaD
Lucanthone—APEX1—saliva-secreting gland—thyroid cancer	0.0118	0.143	CbGeAlD
Lucanthone—APEX1—TSH signaling pathway—PAX8—thyroid cancer	0.0102	0.0659	CbGpPWpGaD
Lucanthone—APEX1—Removal of DNA patch containing abasic residue—SMUG1—thyroid cancer	0.00924	0.0595	CbGpPWpGaD
Lucanthone—APEX1—trachea—thyroid cancer	0.00913	0.11	CbGeAlD
Lucanthone—APEX1—Base Excision Repair—SMUG1—thyroid cancer	0.00845	0.0544	CbGpPWpGaD
Lucanthone—TOP1—saliva-secreting gland—thyroid cancer	0.00828	0.0998	CbGeAlD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.00777	0.05	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RAP1GAP—thyroid cancer	0.00776	0.05	CbGpPWpGaD
Lucanthone—Amiodarone—THRB—thyroid cancer	0.00771	1	CrCbGaD
Lucanthone—APEX1—thyroid gland—thyroid cancer	0.00722	0.0871	CbGeAlD
Lucanthone—APEX1—head—thyroid cancer	0.00641	0.0772	CbGeAlD
Lucanthone—TOP1—trachea—thyroid cancer	0.00639	0.077	CbGeAlD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—EPO—thyroid cancer	0.00595	0.0383	CbGpPWpGaD
Lucanthone—TOP1—thyroid gland—thyroid cancer	0.00505	0.0609	CbGeAlD
Lucanthone—APEX1—lymph node—thyroid cancer	0.00448	0.0541	CbGeAlD
Lucanthone—APEX1—TSH signaling pathway—TSHR—thyroid cancer	0.00446	0.0287	CbGpPWpGaD
Lucanthone—APEX1—Extension of Telomeres—TERT—thyroid cancer	0.0042	0.0271	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NKX2-1—thyroid cancer	0.0042	0.027	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TCF7L1—thyroid cancer	0.00369	0.0238	CbGpPWpGaD
Lucanthone—TOP2A—thyroid gland—thyroid cancer	0.0036	0.0434	CbGeAlD
Lucanthone—TOP1—lymph node—thyroid cancer	0.00314	0.0378	CbGeAlD
Lucanthone—TOP2A—G0 and Early G1—CDK1—thyroid cancer	0.00304	0.0195	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—LGALS3—thyroid cancer	0.00278	0.0179	CbGpPWpGaD
Lucanthone—TOP2A—lymph node—thyroid cancer	0.00223	0.0269	CbGeAlD
Lucanthone—APEX1—DNA Repair—SMUG1—thyroid cancer	0.00203	0.0131	CbGpPWpGaD
Lucanthone—APEX1—Doxorubicin—Epirubicin—thyroid cancer	0.00198	0.201	CbGdCrCtD
Lucanthone—APEX1—Telomere Maintenance—TERT—thyroid cancer	0.0019	0.0123	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDK1—thyroid cancer	0.0019	0.0122	CbGpPWpGaD
Lucanthone—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.00188	0.191	CbGdCrCtD
Lucanthone—APEX1—Epirubicin—Doxorubicin—thyroid cancer	0.00183	0.186	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00177	0.0114	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—BRAF—thyroid cancer	0.00172	0.0111	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—TERT—thyroid cancer	0.00159	0.0102	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.00151	0.00972	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—thyroid cancer	0.00147	0.00947	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PCM1—thyroid cancer	0.00135	0.00869	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00131	0.00845	CbGpPWpGaD
Lucanthone—TOP2A—Afatinib—Vandetanib—thyroid cancer	0.00123	0.125	CbGdCrCtD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—thyroid cancer	0.00116	0.0075	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.00112	0.00721	CbGpPWpGaD
Lucanthone—TOP2A—Gefitinib—Vandetanib—thyroid cancer	0.00108	0.109	CbGdCrCtD
Lucanthone—TOP1—Circadian rythm related genes—PPARG—thyroid cancer	0.00108	0.00692	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000922	0.00594	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000881	0.00567	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—thyroid cancer	0.000875	0.00563	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TPR—thyroid cancer	0.000824	0.00531	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000796	0.00512	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—thyroid cancer	0.000793	0.0051	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—thyroid cancer	0.00079	0.00509	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK1—thyroid cancer	0.000788	0.00507	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000768	0.00495	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—thyroid cancer	0.000765	0.00492	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—thyroid cancer	0.000738	0.00475	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—thyroid cancer	0.000701	0.00452	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—thyroid cancer	0.0007	0.0045	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000698	0.00449	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000625	0.00402	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PCM1—thyroid cancer	0.000624	0.00402	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.00059	0.0038	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK1—thyroid cancer	0.000559	0.0036	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000554	0.00357	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000524	0.00338	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—thyroid cancer	0.000521	0.00335	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—thyroid cancer	0.000503	0.00324	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000466	0.003	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000443	0.00285	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000426	0.00275	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—thyroid cancer	0.000403	0.00259	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TPR—thyroid cancer	0.000381	0.00245	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARG—thyroid cancer	0.000336	0.00216	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—thyroid cancer	0.000328	0.00211	CbGpPWpGaD
Lucanthone—TOP2A—Daunorubicin—Epirubicin—thyroid cancer	0.00032	0.0325	CbGdCrCtD
Lucanthone—TOP2A—Doxorubicin—Epirubicin—thyroid cancer	0.00032	0.0325	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Epirubicin—thyroid cancer	0.00032	0.0325	CbGdCrCtD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.000307	0.00198	CbGpPWpGaD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	0.000296	0.03	CbGdCrCtD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—thyroid cancer	0.000296	0.03	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—thyroid cancer	0.000296	0.03	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000289	0.00186	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000275	0.00177	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.00026	0.00168	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK1—thyroid cancer	0.000258	0.00166	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000249	0.0016	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00024	0.00155	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—thyroid cancer	0.000233	0.0015	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—thyroid cancer	0.00023	0.00148	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—thyroid cancer	0.000186	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000184	0.00119	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000164	0.00105	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—thyroid cancer	0.000157	0.00101	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—thyroid cancer	0.000153	0.000987	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000138	0.00089	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.00012	0.000775	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—thyroid cancer	0.000108	0.000693	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—thyroid cancer	7.09e-05	0.000456	CbGpPWpGaD
